Morgan Stanley raised the firm's price target on Raymond James to $172 from $171 and keeps an Equal Weight rating on the shares. The firm raised its calendar year 2026 and 2027 EPS estimates 7.2% and 0.4%, respectively, on better investment banking revenue and net interest income expectations, partially offset by higher expenses.
